Bioagile Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 22.48%
- Profit Growth 18.95%
- Ebitda 2.58%
- Net Worth 21.59%
- Total Assets 42.56%
About Bioagile Therapeutics
Bioagile Therapeutics Private Limited (BTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 July 2016 (Eight years and six months 22 days old ). Its registered office is in Bangalore North, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shivanna Renukaprabhe and Divya Chandradhara serve as directors at the Company.
Company Details
- Location
Bangalore North, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999KA2016PTC094876
- Company No.
094876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Bioagile Therapeutics Private Limited offer?
Bioagile Therapeutics Private Limited offers a wide range of products and services, including Turnkey Consultants & Solutions, Project Consultants, Business Planning and Management, Business Consultant, Pharma & Bioanalytical Services, Pharmaceutical Services, Copywriting & Content Development, Content Writing Service.
Who are the key members and board of directors at Bioagile Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Chandradhara  | Director | 11-Jul-2016 | Current |
| Shivanna Renukaprabhe | Director | 15-Feb-2017 | Current |
Financial Performance of Bioagile Therapeutics.
Bioagile Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.48% increase. The company also saw a substantial improvement in profitability, with a 18.95% increase in profit. The company's net worth Soared by an impressive increase of 21.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioagile Therapeutics?
In 2022, Bioagile Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nexvaxi Therapeutics Private LimitedShivanna Renukaprabhe and Divya Chandradhara are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioagile Therapeutics?
Unlock and access historical data on people associated with Bioagile Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioagile Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioagile Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
